Annual Current Liabilities
$42.77 M
-$1.78 M-4.00%
31 December 2023
Summary:
C4 Therapeutics annual total current liabilities is currently $42.77 million, with the most recent change of -$1.78 million (-4.00%) on 31 December 2023. During the last 3 years, it has fallen by -$1.09 million (-2.48%). CCCC annual current liabilities is now -16.55% below its all-time high of $51.25 million, reached on 31 December 2021.CCCC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$43.29 M
-$10.91 M-20.13%
30 September 2024
Summary:
C4 Therapeutics quarterly total current liabilities is currently $43.29 million, with the most recent change of -$10.91 million (-20.13%) on 30 September 2024. Over the past year, it has increased by +$13.02 million (+43.02%). CCCC quarterly current liabilities is now -21.31% below its all-time high of $55.02 million, reached on 31 March 2024.CCCC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.0% | +43.0% |
| 3 y3 years | -2.5% | -11.1% |
| 5 y5 years | +78.6% | - |
CCCC Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.6% | at low | -21.3% | +43.0% |
| 5 y | 5 years | -16.6% | +78.6% | -21.3% | +43.0% |
| alltime | all time | -16.6% | +78.6% | -21.3% | +43.0% |
C4 Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.29 M(-20.1%) |
| June 2024 | - | $54.20 M(-1.5%) |
| Mar 2024 | - | $55.02 M(+28.6%) |
| Dec 2023 | $42.77 M(-4.0%) | $42.77 M(+41.3%) |
| Sept 2023 | - | $30.27 M(-37.2%) |
| June 2023 | - | $48.24 M(+22.5%) |
| Mar 2023 | - | $39.38 M(-11.6%) |
| Dec 2022 | $44.55 M | $44.55 M(-1.6%) |
| Sept 2022 | - | $45.27 M(-1.9%) |
| June 2022 | - | $46.15 M(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $46.99 M(-8.3%) |
| Dec 2021 | $51.25 M(+16.9%) | $51.25 M(+5.3%) |
| Sept 2021 | - | $48.69 M(+10.2%) |
| June 2021 | - | $44.17 M(+17.3%) |
| Mar 2021 | - | $37.65 M(-14.1%) |
| Dec 2020 | $43.85 M(+30.4%) | $43.85 M(+9.6%) |
| Sept 2020 | - | $40.01 M(+13.9%) |
| June 2020 | - | $35.11 M(+4.4%) |
| Dec 2019 | $33.64 M(+40.5%) | $33.64 M |
| Dec 2018 | $23.95 M | - |
FAQ
- What is C4 Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for C4 Therapeutics?
- What is C4 Therapeutics annual current liabilities year-on-year change?
- What is C4 Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for C4 Therapeutics?
- What is C4 Therapeutics quarterly current liabilities year-on-year change?
What is C4 Therapeutics annual total current liabilities?
The current annual current liabilities of CCCC is $42.77 M
What is the all time high annual current liabilities for C4 Therapeutics?
C4 Therapeutics all-time high annual total current liabilities is $51.25 M
What is C4 Therapeutics annual current liabilities year-on-year change?
Over the past year, CCCC annual total current liabilities has changed by -$1.78 M (-4.00%)
What is C4 Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CCCC is $43.29 M
What is the all time high quarterly current liabilities for C4 Therapeutics?
C4 Therapeutics all-time high quarterly total current liabilities is $55.02 M
What is C4 Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CCCC quarterly total current liabilities has changed by +$13.02 M (+43.02%)